SCHEMBL20219543

SCHEMBL20219543

CCCCNc1nc(C)ncc1OCCOCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR8 Q9NR97 11/20 0.47
▸ TLR7 Q9NYK1 10/20 0.47
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CASP6 P55212 1/20 0.40
▸ NPY5R Q15761 1/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ TYRO3 Q06418 1/20 0.38
▸ MERTK Q12866 1/20 0.38
▸ GAS6 Q14393 1/20 0.38
▸ SLC2A1 P11166 1/20 0.38
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13195805 0.88 TLR7 (0.57) TLR8TLR7CYP1A2CYP2D6CYP3A4
SCHEMBL23472323 0.85 TLR8 (0.54) TLR8TLR7CYP1A2CYP2D6CASP6
SCHEMBL23472526 0.82 TLR8 (0.47) TLR8TLR7CYP3A4ALDH1A1LMNA
SCHEMBL23472288 0.80 TLR8 (0.38) TLR8TLR7CYP3A4LMNASMN1; SMN2
SCHEMBL20219396 0.80 TLR8 (0.35) TLR8TLR7NPY5RCYP3A4ALDH1A1
SCHEMBL20219386 0.79 SCN9A (0.36) TLR8TLR7NPY5RCYP3A4ALDH1A1
SCHEMBL20219430 0.79 TLR7 (0.42) TLR8TLR7CYP1A2CYP2D6CYP3A4
SCHEMBL15469746 0.79 TLR8 (0.41) TLR8TLR7CYP1A2CYP2D6CASP6
SCHEMBL20219381 0.78 TLR8 (0.34) TLR8TLR7NPY5RCYP3A4ALDH1A1
SCHEMBL20219471 0.78 NPSR1 (0.44) TLR8TLR7CYP1A2CYP2D6CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback